feed,title,long_url,short_url
BioRxiv,Rapid and Effective Inactivation of SARS-CoV-2 by a Cationic Conjugated Oligomer with Visible Light: Studies of Antiviral Activity in Solutions and on Supports,https://biorxiv.org/cgi/content/short/2021.10.18.464882v1?rss=1,https://j.mp/3G4MB2Q
BioRxiv,δ1 variant of SARS-COV-2 acquires spike V1176F and yields a highly mutated subvariant in Europe,https://biorxiv.org/cgi/content/short/2021.10.16.463825v1?rss=1,https://j.mp/3DXJWpO
BioRxiv,SARS-COV-2 C.1.2 variant is highly mutated but may possess reduced affinity for ACE2 receptor,https://biorxiv.org/cgi/content/short/2021.10.16.464644v1?rss=1,https://j.mp/3B10bk2
BioRxiv,SARS-COV-2 γ variant acquires spike P681H or P681R for improved viral fitness,https://biorxiv.org/cgi/content/short/2021.10.16.464641v1?rss=1,https://j.mp/3pg8xlB
BioRxiv,"Preclinical Efficacy of IMM-BCP-01, a Highly Active Patient-Derived Anti-SARS-CoV-2 Antibody Cocktail",https://biorxiv.org/cgi/content/short/2021.10.18.464900v1?rss=1,https://j.mp/3AWOKtN
